SCHEMBL17778284

SCHEMBL17778284

C=Cc1nc(C(=O)NCc2ccccc2C(F)(F)F)c(N)nc1-n1ccc(C)n1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 1/20 0.47
▸ CNR2 P34972 1/20 0.47
▸ MEN1 O00255 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAPK10 P53779 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ADORA2A P29274 2/20 0.40
▸ ADORA1 P30542 2/20 0.40
▸ ADORA2B P29275 1/20 0.39
▸ KLKB1 P03952 1/20 0.39
▸ EPHX2 P34913 9/20 0.38
▸ PPARG P37231 3/20 0.37
▸ CACNA1G O43497 1/20 0.37
▸ CACNA1H O95180 1/20 0.37
▸ P2RY14 Q15391 1/20 0.37
▸ PTGES O14684 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17768753 0.87 CNR1 (0.49) CNR1CNR2MEN1CYP1A2CYP2D6
SCHEMBL17778279 0.86 CNR1 (0.46) CNR1CNR2MEN1CYP1A2CYP2D6
SCHEMBL17778078 0.84 CNR1 (0.47) CNR1CNR2MEN1CYP1A2CYP2D6
SCHEMBL12629799 0.73 CNR1 (0.57) CNR1CNR2MEN1CYP1A2CYP2D6
SCHEMBL17768739 0.72 CNR1 (0.48) CNR1CNR2MEN1CYP1A2CYP2D6
SCHEMBL17769156 0.72 CNR1 (0.48) CNR1CNR2MEN1CYP1A2CYP2D6
SCHEMBL22552131 0.71 ADORA2A (0.51) MEN1HPGDKMT2AADORA2AADORA1
SCHEMBL17768901 0.71 CNR1 (0.46) CNR1CNR2ADORA2AADORA1EPHX2
SCHEMBL29907526 0.71 ADORA2A (0.51) MEN1HPGDKMT2AADORA2AADORA1
SCHEMBL17768668 0.71 CNR1 (0.49) CNR1CNR2MEN1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016081290-A1 AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES MERCK SHARP & DOHME CORP. (US) 2016-05-26 — — WO disclosed
Send feedback